Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print November 6, 2006, 10.1110/ps.062465306
Protein Science (2006), 15:2795-2804. Published by Cold Spring Harbor Laboratory Press. Copyright © 2006 The Protein Society
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Research Data
Right arrow All Versions of this Article:
ps.062465306v1
15/12/2795    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marsh, J. A.
Right arrow Articles by Forman-Kay, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marsh, J. A.
Right arrow Articles by Forman-Kay, J. D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Sensitivity of secondary structure propensities to sequence differences between {alpha}- and {gamma}-synuclein: Implications for fibrillation

Joseph A. Marsh1,2, Vinay K. Singh3, Zongchao Jia3, and Julie D. Forman-Kay1,2

1 Molecular Structure and Function, Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada
2 Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada
3 Department of Biochemistry, Queen's University, Kingston, Ontario K7L 3N6, Canada

(RECEIVED July 27, 2006; FINAL REVISION September 14, 2006; ACCEPTED September 14, 2006)

The synucleins are a family of intrinsically disordered proteins involved in various human diseases. {alpha}-Synuclein has been extensively characterized due to its role in Parkinson's disease where it forms intracellular aggregates, while {gamma}-synuclein is overexpressed in a majority of late-stage breast cancers. Despite fairly strong sequence similarity between the amyloid-forming regions of {alpha}- and {gamma}-synuclein, {gamma}-synuclein has only a weak propensity to form amyloid fibrils. We hypothesize that the different fibrillation tendencies of {alpha}- and {gamma}-synuclein may be related to differences in structural propensities. Here we have measured chemical shifts for {gamma}-synuclein and compared them to previously published shifts for {alpha}-synuclein. In order to facilitate direct comparison, we have implemented a simple new technique for re-referencing chemical shifts that we have found to be highly effective for both disordered and folded proteins. In addition, we have developed a new method that combines different chemical shifts into a single residue-specific secondary structure propensity (SSP) score. We observe significant differences between {alpha}- and {gamma}-synuclein secondary structure propensities. Most interestingly, {gamma}-synuclein has an increased {alpha}-helical propensity in the amyloid-forming region that is critical for {alpha}-synuclein fibrillation, suggesting that increased structural stability in this region may protect against {gamma}-synuclein aggregation. This comparison of residue-specific secondary structure propensities between intrinsically disordered homologs highlights the sensitivity of transient structure to sequence changes, which we suggest may have been exploited as an evolutionary mechanism for fast modulation of protein structure and, hence, function.

Keywords: SNCG; NMR; residual structure; secondary chemical shifts; chemical shift re-referencing



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Mittag, S. Orlicky, W.-Y. Choy, X. Tang, H. Lin, F. Sicheri, L. E. Kay, M. Tyers, and J. D. Forman-Kay
Dynamic equilibrium engagement of a polyvalent ligand with a single-site receptor
PNAS, November 18, 2008; 105(46): 17772 - 17777.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
R. L. Croke, C. O. Sallum, E. Watson, E. D. Watt, and A. T. Alexandrescu
Hydrogen exchange of monomeric {alpha}-synuclein shows unfolded structure persists at physiological temperature and is independent of molecular crowding in Escherichia coli
Protein Sci., August 1, 2008; 17(8): 1434 - 1445.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
D. S. Libich and G. Harauz
Backbone Dynamics of the 18.5 kDa Isoform of Myelin Basic Protein Reveals Transient {alpha}-Helices and a Calmodulin-Binding Site
Biophys. J., June 15, 2008; 94(12): 4847 - 4866.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
D. S. Weinstock, C. Narayanan, J. Baum, and R. M. Levy
Correlation between 13C {alpha} chemical shifts and helix content of peptide ensembles
Protein Sci., May 1, 2008; 17(5): 950 - 954.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Song, L.-W. Guo, H. Muradov, N. O. Artemyev, A. E. Ruoho, and J. L. Markley
Intrinsically disordered {gamma}-subunit of cGMP phosphodiesterase encodes functionally relevant transient secondary and tertiary structure
PNAS, February 5, 2008; 105(5): 1505 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
C. Gall, H. Xu, A. Brickenden, X. Ai, and W. Y. Choy
The intrinsically disordered TC-1 interacts with Chibby via regions with high helical propensity
Protein Sci., November 1, 2007; 16(11): 2510 - 2518.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. K. Singh, Y. Zhou, J. A. Marsh, V. N. Uversky, J. D. Forman-Kay, J. Liu, and Z. Jia
Synuclein-{gamma} Targeting Peptide Inhibitor that Enhances Sensitivity of Breast Cancer Cells to Antimicrotubule Drugs
Cancer Res., January 15, 2007; 67(2): 626 - 633.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Protein Society.